Lilly new Corporate Partner of 5-HT

We are very pleased to announce Lilly Deutschland GmbH as our new Corporate Partner.

Lilly Deutschland is the German affiliate of Eli Lilly and Company, one of the world's leading pharmaceutical companies. Since its founding, the company has achieved significant breakthroughs in areas such as insulin, polio vaccination and in the treatment of mental illness. Lilly has been operating in Germany since 1960, with its main site in Bad Homburg.

To fully realize the potential for digital health, collaboration among players in the health care ecosystem is important. Therefore, as one of the largest research-based pharmaceutical companies in the world, Lilly is committed to establish digital health projects and partnerships. 

Our common goal is to connect and collaborate to build upon great ideas so that we can ultimately develop solutions for the people who need them.

Niko Louris, Manager Digital Health Innovation at Lilly: „Digitalization has the potential to transform healthcare, but we need to join forces and work in an open ecosystem to make this happen." 

Dr. Frank Funke, Managing Director of 5-HT Digital Hub Chemistry & Health: „As a new corporate partner, Lilly supports our goals of promoting digital health in a variety of ways and adds another active player to our already strong network. We look forward to working together.“